REPORTS

Let’s Pullulate and Expand Your Business

Global Biopharmaceuticals Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 14, 2020  |  209 PAGES  |  REPORT CODE: CMM368199
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

It is costly to discover and develop new drugs/medicines due to expensive research processes, Costs associated with clinical trials, resource-intensive approval procedures and costs associatedWith manufacturing (if the trials are successful).An additional point is that European R&D costs are higher than in other world regions due to the fragmented European patent system. The implications of a fragmented patent system in Europe include high uncertainty, quality drop and prohibitive costs, which are at least four times higher than in the US, China and South Korea thus constituting a financial burden on especially small biopharmaceutical enterprises in Europe (van Pottelsberghe 2009).

The Biopharmaceuticals is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period. The research provides insights for the global Biopharmaceuticals market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Biopharmaceuticals industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Biopharmaceuticals Market Segmentations:

By Players:

  • Roche

  • Amgen

  • AbbVie

  • Sanofi-Aventis

  • Johnson & Johnson

  • Pfizer

  • Novo Nordisk

  • Eli Lilly

  • Novartis

  • Merck

By Types:

  • Monoclonal Antibodies

  • Interferon

  • Colony-Stimulating Factor

  • Erythropoietin

  • Insulin

  • Vaccines

  • Growth Hormones

  • Others

By End-User:

  • Tumor

  • Diabetes

  • Cardiovascular

  • Hemophilia

  • Others

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biopharmaceuticals Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Biopharmaceuticals Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026

    • 1.3.2 Global Biopharmaceuticals Market Size and Growth Rate of Interferon from 2014 to 2026

    • 1.3.3 Global Biopharmaceuticals Market Size and Growth Rate of Colony-Stimulating Factor from 2014 to 2026

    • 1.3.4 Global Biopharmaceuticals Market Size and Growth Rate of Erythropoietin from 2014 to 2026

    • 1.3.5 Global Biopharmaceuticals Market Size and Growth Rate of Insulin from 2014 to 2026

    • 1.3.6 Global Biopharmaceuticals Market Size and Growth Rate of Vaccines from 2014 to 2026

    • 1.3.7 Global Biopharmaceuticals Market Size and Growth Rate of Growth Hormones from 2014 to 2026

    • 1.3.8 Global Biopharmaceuticals Market Size and Growth Rate of Others from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Biopharmaceuticals Market Size and Growth Rate of Tumor from 2014 to 2026

    • 1.4.2 Global Biopharmaceuticals Market Size and Growth Rate of Diabetes from 2014 to 2026

    • 1.4.3 Global Biopharmaceuticals Market Size and Growth Rate of Cardiovascular from 2014 to 2026

    • 1.4.4 Global Biopharmaceuticals Market Size and Growth Rate of Hemophilia from 2014 to 2026

    • 1.4.5 Global Biopharmaceuticals Market Size and Growth Rate of Others from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Biopharmaceuticals Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Biopharmaceuticals Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Biopharmaceuticals by Major Types

    • 3.4.1 Biopharmaceuticals Market Size and Growth Rate of Monoclonal Antibodies

    • 3.4.2 Biopharmaceuticals Market Size and Growth Rate of Interferon

    • 3.4.3 Biopharmaceuticals Market Size and Growth Rate of Colony-Stimulating Factor

    • 3.4.4 Biopharmaceuticals Market Size and Growth Rate of Erythropoietin

    • 3.4.5 Biopharmaceuticals Market Size and Growth Rate of Insulin

    • 3.4.6 Biopharmaceuticals Market Size and Growth Rate of Vaccines

    • 3.4.7 Biopharmaceuticals Market Size and Growth Rate of Growth Hormones

    • 3.4.8 Biopharmaceuticals Market Size and Growth Rate of Others

4 Segmentation of Biopharmaceuticals Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Biopharmaceuticals by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Biopharmaceuticals in Tumor

    • 4.4.2 Market Size and Growth Rate of Biopharmaceuticals in Diabetes

    • 4.4.3 Market Size and Growth Rate of Biopharmaceuticals in Cardiovascular

    • 4.4.4 Market Size and Growth Rate of Biopharmaceuticals in Hemophilia

    • 4.4.5 Market Size and Growth Rate of Biopharmaceuticals in Others

5 Market Analysis by Major Regions

  • 5.1 Global Biopharmaceuticals Production Analysis by Major Regions

  • 5.2 Global Biopharmaceuticals Consumption Analysis by Major Regions

  • 5.3 Global Biopharmaceuticals Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Biopharmaceuticals Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Biopharmaceuticals Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Biopharmaceuticals Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Biopharmaceuticals Production, Import, Consumption and Export Analysis

6 Product Commodity of Biopharmaceuticals Market in Major Countries

  • 6.1 Top 5 Export Countries in Biopharmaceuticals market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Biopharmaceuticals market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Biopharmaceuticals market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Biopharmaceuticals market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Biopharmaceuticals market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Biopharmaceuticals market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Biopharmaceuticals Landscape Analysis

  • 7.1 North America Biopharmaceuticals Landscape Analysis by Major Types

  • 7.2 North America Biopharmaceuticals Landscape Analysis by Major End-Users

  • 7.3 North America Biopharmaceuticals Landscape Analysis by Major Countries

    • 7.3.1 United States Biopharmaceuticals Market Volume and Growth Rate

    • 7.3.2 Canada Biopharmaceuticals Market Volume and Growth Rate

    • 7.3.3 Mexico Biopharmaceuticals Market Volume and Growth Rate

8 Europe Biopharmaceuticals Landscape Analysis

  • 8.1 Europe Biopharmaceuticals Landscape Analysis by Major Types

  • 8.2 Europe Biopharmaceuticals Landscape Analysis by Major End-Users

  • 8.3 Europe Biopharmaceuticals Landscape Analysis by Major Countries

    • 8.3.1 Germany Biopharmaceuticals Market Volume and Growth Rate

    • 8.3.2 UK Biopharmaceuticals Market Volume and Growth Rate

    • 8.3.3 France Biopharmaceuticals Market Volume and Growth Rate

    • 8.3.4 Italy Biopharmaceuticals Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Biopharmaceuticals Market Volume and Growth Rate

    • 8.3.6 Spain Biopharmaceuticals Market Volume and Growth Rate

    • 8.3.7 Belgium Biopharmaceuticals Market Volume and Growth Rate

    • 8.3.8 Poland Biopharmaceuticals Market Volume and Growth Rate

    • 8.3.9 Russia Biopharmaceuticals Market Volume and Growth Rate

    • 8.3.10 Turkey Biopharmaceuticals Market Volume and Growth Rate

9 Asia Pacific Biopharmaceuticals Landscape Analysis

  • 9.1 Asia Pacific Biopharmaceuticals Landscape Analysis by Major Types

  • 9.2 Asia Pacific Biopharmaceuticals Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Biopharmaceuticals Landscape Analysis by Major Countries

    • 9.3.1 China Biopharmaceuticals Market Volume and Growth Rate

    • 9.3.2 Japan Biopharmaceuticals Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Biopharmaceuticals Market Volume and Growth Rate

    • 9.3.4 India Biopharmaceuticals Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Biopharmaceuticals Market Volume and Growth Rate

    • 9.3.6 South Korea Biopharmaceuticals Market Volume and Growth Rate

10 Latin America, Middle East & Africa Biopharmaceuticals Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Biopharmaceuticals Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Biopharmaceuticals Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Biopharmaceuticals Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Biopharmaceuticals Market Volume and Growth Rate

    • 10.3.2 Brazil Biopharmaceuticals Market Volume and Growth Rate

    • 10.3.3 Nigeria Biopharmaceuticals Market Volume and Growth Rate

    • 10.3.4 South Africa Biopharmaceuticals Market Volume and Growth Rate 

    • 10.3.5 Argentina Biopharmaceuticals Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Roche

    • 11.1.1 Roche Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Amgen

    • 11.2.1 Amgen Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 AbbVie

    • 11.3.1 AbbVie Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Sanofi-Aventis

    • 11.4.1 Sanofi-Aventis Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Johnson & Johnson

    • 11.5.1 Johnson & Johnson Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Pfizer

    • 11.6.1 Pfizer Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Novo Nordisk

    • 11.7.1 Novo Nordisk Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Eli Lilly

    • 11.8.1 Eli Lilly Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Novartis

    • 11.9.1 Novartis Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Merck

    • 11.10.1 Merck Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 115 Figures and 135 Tables)

  • Figure Product Picture

  • Figure Biopharmaceuticals Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026

  • Figure Biopharmaceuticals Market Size and Growth Rate of Interferon from 2014 to 2026

  • Figure Biopharmaceuticals Market Size and Growth Rate of Colony-Stimulating Factor from 2014 to 2026

  • Figure Biopharmaceuticals Market Size and Growth Rate of Erythropoietin from 2014 to 2026

  • Figure Biopharmaceuticals Market Size and Growth Rate of Insulin from 2014 to 2026

  • Figure Biopharmaceuticals Market Size and Growth Rate of Vaccines from 2014 to 2026

  • Figure Biopharmaceuticals Market Size and Growth Rate of Growth Hormones from 2014 to 2026

  • Figure Biopharmaceuticals Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Biopharmaceuticals Market Size and Growth Rate of Tumor from 2014 to 2026

  • Figure Global Biopharmaceuticals Market Size and Growth Rate of Diabetes from 2014 to 2026

  • Figure Global Biopharmaceuticals Market Size and Growth Rate of Cardiovascular from 2014 to 2026

  • Figure Global Biopharmaceuticals Market Size and Growth Rate of Hemophilia from 2014 to 2026

  • Figure Global Biopharmaceuticals Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Biopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Biopharmaceuticals Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Biopharmaceuticals

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Biopharmaceuticals by Different Types from 2014 to 2026

  • Table Consumption Share of Biopharmaceuticals by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Monoclonal Antibodies

  • Figure Market Size and Growth Rate of Interferon

  • Figure Market Size and Growth Rate of Colony-Stimulating Factor

  • Figure Market Size and Growth Rate of Erythropoietin

  • Figure Market Size and Growth Rate of Insulin

  • Figure Market Size and Growth Rate of Vaccines

  • Figure Market Size and Growth Rate of Growth Hormones

  • Figure Market Size and Growth Rate of Others

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Biopharmaceuticals by Different End-Users from 2014 to 2026

  • Table Consumption Share of Biopharmaceuticals by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Tumor

  • Figure Market Size and Growth Rate of Diabetes

  • Figure Market Size and Growth Rate of Cardiovascular

  • Figure Market Size and Growth Rate of Hemophilia

  • Figure Market Size and Growth Rate of Others

  • Table Global Biopharmaceuticals Production by Major Regions

  • Table Global Biopharmaceuticals Production Share by Major Regions

  • Figure Global Biopharmaceuticals Production Share by Major Regions in 2014

  • Figure Global Biopharmaceuticals Production Share by Major Regions in 2018

  • Figure Global Biopharmaceuticals Production Share by Major Regions in 2026

  • Table Global Biopharmaceuticals Consumption by Major Regions

  • Table Global Biopharmaceuticals Consumption Share by Major Regions

  • Figure Global Biopharmaceuticals Consumption Share by Major Regions in 2014

  • Figure Global Biopharmaceuticals Consumption Share by Major Regions in 2018

  • Figure Global Biopharmaceuticals Consumption Share by Major Regions in 2026

  • Table North America Biopharmaceuticals Production, Import, Consumption and Export Analysis

  • Table Europe Biopharmaceuticals Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Biopharmaceuticals Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Biopharmaceuticals Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Biopharmaceuticals market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Biopharmaceuticals market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Biopharmaceuticals market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Biopharmaceuticals market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Biopharmaceuticals Consumption by Types from 2014 to 2026

  • Table North America Biopharmaceuticals Consumption Share by Types from 2014 to 2026

  • Figure North America Biopharmaceuticals Consumption Share by Types in 2014

  • Figure North America Biopharmaceuticals Consumption Share by Types in 2018

  • Figure North America Biopharmaceuticals Consumption Share by Types in 2026

  • Table North America Biopharmaceuticals Consumption by End-Users from 2014 to 2026

  • Table North America Biopharmaceuticals Consumption Share by End-Users from 2014 to 2026

  • Figure North America Biopharmaceuticals Consumption Share by End-Users in 2014

  • Figure North America Biopharmaceuticals Consumption Share by End-Users in 2018

  • Figure North America Biopharmaceuticals Consumption Share by End-Users in 2026

  • Table North America Biopharmaceuticals Consumption by Major Countries from 2014 to 2026

  • Table North America Biopharmaceuticals Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Biopharmaceuticals Consumption Share by Major Countries in 2014

  • Figure North America Biopharmaceuticals Consumption Share by Major Countries in 2018

  • Figure North America Biopharmaceuticals Consumption Share by Major Countries in 2026

  • Figure United States Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Biopharmaceuticals Consumption by Types from 2014 to 2026

  • Table Europe Biopharmaceuticals Consumption Share by Types from 2014 to 2026

  • Figure Europe Biopharmaceuticals Consumption Share by Types in 2014

  • Figure Europe Biopharmaceuticals Consumption Share by Types in 2018

  • Figure Europe Biopharmaceuticals Consumption Share by Types in 2026

  • Table Europe Biopharmaceuticals Consumption by End-Users from 2014 to 2026

  • Table Europe Biopharmaceuticals Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Biopharmaceuticals Consumption Share by End-Users in 2014

  • Figure Europe Biopharmaceuticals Consumption Share by End-Users in 2018

  • Figure Europe Biopharmaceuticals Consumption Share by End-Users in 2026

  • Table Europe Biopharmaceuticals Consumption by Major Countries from 2014 to 2026

  • Table Europe Biopharmaceuticals Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Biopharmaceuticals Consumption Share by Major Countries in 2014

  • Figure Europe Biopharmaceuticals Consumption Share by Major Countries in 2018

  • Figure Europe Biopharmaceuticals Consumption Share by Major Countries in 2026

  • Figure Germany Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure France Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Biopharmaceuticals Consumption by Types from 2014 to 2026

  • Table Asia Pacific Biopharmaceuticals Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Biopharmaceuticals Consumption Share by Types in 2014

  • Figure Asia Pacific Biopharmaceuticals Consumption Share by Types in 2018

  • Figure Asia Pacific Biopharmaceuticals Consumption Share by Types in 2026

  • Table Asia Pacific Biopharmaceuticals Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Biopharmaceuticals Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Biopharmaceuticals Consumption Share by End-Users in 2014

  • Figure Asia Pacific Biopharmaceuticals Consumption Share by End-Users in 2018

  • Figure Asia Pacific Biopharmaceuticals Consumption Share by End-Users in 2026

  • Table Asia Pacific Biopharmaceuticals Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Biopharmaceuticals Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Biopharmaceuticals Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Biopharmaceuticals Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Biopharmaceuticals Consumption Share by Major Countries in 2026

  • Figure China Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandBiopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure India Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Biopharmaceuticals Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Biopharmaceuticals Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Biopharmaceuticals Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Biopharmaceuticals Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Biopharmaceuticals Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Biopharmaceuticals Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Biopharmaceuticals Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Biopharmaceuticals Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Biopharmaceuticals Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Biopharmaceuticals Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Biopharmaceuticals Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Biopharmaceuticals Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Biopharmaceuticals Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Biopharmaceuticals Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Biopharmaceuticals Consumption Share by Major Countries in 2026

  • Figure GCC Countries Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Biopharmaceuticals Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Roche

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

  • Figure Sales and Growth Rate Analysis of Roche

  • Figure Revenue and Market Share Analysis of Roche

  • Table Product and Service Introduction of Roche

  • Table Company Profile and Development Status of Amgen

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

  • Figure Sales and Growth Rate Analysis of Amgen

  • Figure Revenue and Market Share Analysis of Amgen

  • Table Product and Service Introduction of Amgen

  • Table Company Profile and Development Status of AbbVie

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

  • Figure Sales and Growth Rate Analysis of AbbVie

  • Figure Revenue and Market Share Analysis of AbbVie

  • Table Product and Service Introduction of AbbVie

  • Table Company Profile and Development Status of Sanofi-Aventis

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis

  • Figure Sales and Growth Rate Analysis of Sanofi-Aventis

  • Figure Revenue and Market Share Analysis of Sanofi-Aventis

  • Table Product and Service Introduction of Sanofi-Aventis

  • Table Company Profile and Development Status of Johnson & Johnson

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

  • Figure Sales and Growth Rate Analysis of Johnson & Johnson

  • Figure Revenue and Market Share Analysis of Johnson & Johnson

  • Table Product and Service Introduction of Johnson & Johnson

  • Table Company Profile and Development Status of Pfizer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

  • Figure Sales and Growth Rate Analysis of Pfizer

  • Figure Revenue and Market Share Analysis of Pfizer

  • Table Product and Service Introduction of Pfizer

  • Table Company Profile and Development Status of Novo Nordisk

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

  • Figure Sales and Growth Rate Analysis of Novo Nordisk

  • Figure Revenue and Market Share Analysis of Novo Nordisk

  • Table Product and Service Introduction of Novo Nordisk

  • Table Company Profile and Development Status of Eli Lilly

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

  • Figure Sales and Growth Rate Analysis of Eli Lilly

  • Figure Revenue and Market Share Analysis of Eli Lilly

  • Table Product and Service Introduction of Eli Lilly

  • Table Company Profile and Development Status of Novartis

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

  • Figure Sales and Growth Rate Analysis of Novartis

  • Figure Revenue and Market Share Analysis of Novartis

  • Table Product and Service Introduction of Novartis

  • Table Company Profile and Development Status of Merck

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

  • Figure Sales and Growth Rate Analysis of Merck

  • Figure Revenue and Market Share Analysis of Merck

  • Table Product and Service Introduction of Merck


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top